DR. SUMITHRA VATTIGUNTA (MD) – Hematology & Oncology Physician, NPI 1598785966
Hematology & Oncology Physician
Main info
Doctor Profile
Profile Insights
NPPES metrics only — not quality of care.
1,007 HEMATOLOGY/ONCOLOGY in FL
Loading map...
Provider Addresses for DR. SUMITHRA VATTIGUNTA (MD)
PO BOX 102222
ATLANTA, GA 303682222
Phone: (239) 274-8200
Fax: (239) 278-3350
Type: Mailing
Veronica S Shoemaker Blvd, Fort Myers, Lee County, Florida, 33916, United States
ATTN CREDENTIALING
FORT MYERS, FL 339162216
Phone: (239) 274-8200
Fax: (239) 278-3350
Type: Mailing
PGA Boulevard, Monet, Palm Beach Gardens, Palm Beach County, Florida, 33418, United States
FLORIDA CANCER SPECIALISTS
PALM BEACH GARDENS, FL 334102824
Phone: (561) 366-4100
Fax: (561) 798-5581
Type: Location
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 512 Open Payments records for all available years, with a total value of $12,758.
Total Amount is formed as General ($12,758) + Research ($0) + Ownership ($0) = $12,758.
Last reported payment date: 2024-12-18 • Largest payer in this snapshot: Pharmacosmos Therapeutics Inc. ($2,637).
Total Amount
$12,758
General + Research + Ownership
Payments
512
Total payment records
General Amount
$12,758
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-12-18
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| Pharmacosmos Therapeutics Inc. | $2,637 |
| Novartis Pharmaceuticals Corporation | $1,830 |
| Janssen Biotech, Inc. | $808 |
| Celgene Corporation | $416 |
| AstraZeneca Pharmaceuticals LP | $394 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2005-02-18
PECOS data refreshed: 2026-05-27
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking this Medicare enrollment for revalidation, but has not published a due date.
Enrollment records
1
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20050218000507 | I | Hematology/Oncology | FL | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| Q5101 | Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 28,740 | 18 | $0 |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 14,280 | 17 | $0 |
| J0185 | Injection, aprepitant, 1 mg | 10,530 | 18 | $0 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 7,610 | 74 | $0 |
| J0897 | Injection, denosumab, 1 mg | 3,780 | 23 | $0 |
Insurance plans in this area (ZIP 30368)
Loading plans...
Provider's Procedures
| Specialty | Practice State | HCPCS Code | Description | Service Count | Beneficiary Count |
|---|---|---|---|---|---|
| HEMATOLOGY/ONCOLOGY | FL | 74177 | CT scan of abdomen and pelvis with contrast | 103 | 49 |
| HEMATOLOGY/ONCOLOGY | FL | 81002 | Urinalysis, manual test | 46 | 14 |
| HEMATOLOGY/ONCOLOGY | FL | 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | 521 | 99 |
| HEMATOLOGY/ONCOLOGY | FL | 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 97 | 29 |
Group practice members
| Name | Specialty | State |
|---|---|---|
| Medical Oncology | FL | |
| Medical Oncology, Hematology/Oncology | FL | |
| H E M A T O L O G Y/ O N C O L O G Y | FL | |
| H E M A T O L O G Y/ O N C O L O G Y | FL | |
| Internal Medicine, Hematology/Oncology | FL | |
| - | GA | |
| Hematology/Oncology, Internal Medicine | GA | |
| H E M A T O L O G Y/ O N C O L O G Y | FL | |
| Hospice/Palliative Care, Internal Medicine | FL | |
| H E M A T O L O G Y/ O N C O L O G Y | GA |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.